NFKB1 and breast cancer: pNF-κB p65/ NF-κB p65 levels were significantly lower than that of the BC and GP groups after BC/GP treatment (p < 0.01, Fig. 8a), indicating the efficacy of BC/GP was superior to that of BC and GP.